Literature DB >> 27588171

Gene mutations in Cushing's disease.

Qi Xiong1, Wei Ge2.   

Abstract

Cushing's disease (CD) is a severe (and potentially fatal) disease caused by adrenocorticotropic hormone (ACTH)-secreting adenomas of the pituitary gland (often termed pituitary adenomas). The majority of ACTH-secreting corticotroph tumors are sporadic and CD rarely appears as a familial disorder, thus, the genetic mechanisms underlying CD are poorly understood. Studies have reported that various mutated genes are associated with CD, such as those in menin 1, aryl hydrocarbon receptor-interacting protein and the nuclear receptor subfamily 3 group C member 1. Recently it was identified that ubiquitin-specific protease 8 mutations contribute to CD, which was significant towards elucidating the genetic mechanisms of CD. The present study reviews the associated gene mutations in CD patients.

Entities:  

Keywords:  Cushing's disease; adrenocorticotropic hormone; gene mutation; pituitary adenomas

Year:  2016        PMID: 27588171      PMCID: PMC4998087          DOI: 10.3892/br.2016.729

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  61 in total

1.  Murine leukemia inhibitory factor gene disruption attenuates the hypothalamo-pituitary-adrenal axis stress response.

Authors:  V Chesnokova; C J Auernhammer; S Melmed
Journal:  Endocrinology       Date:  1998-05       Impact factor: 4.736

2.  Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression.

Authors:  M W Nachtigal; Y Hirokawa; D L Enyeart-VanHouten; J N Flanagan; G D Hammer; H A Ingraham
Journal:  Cell       Date:  1998-05-01       Impact factor: 41.582

3.  Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing.

Authors:  A Grishok; A E Pasquinelli; D Conte; N Li; S Parrish; I Ha; D L Baillie; A Fire; G Ruvkun; C C Mello
Journal:  Cell       Date:  2001-07-13       Impact factor: 41.582

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

Review 5.  Genetic mutations in sporadic pituitary adenomas--what to screen for?

Authors:  Anne-Lise Lecoq; Peter Kamenický; Anne Guiochon-Mantel; Philippe Chanson
Journal:  Nat Rev Endocrinol       Date:  2014-10-28       Impact factor: 43.330

Review 6.  Genetics of Cushing's disease: an update.

Authors:  L G Perez-Rivas; M Reincke
Journal:  J Endocrinol Invest       Date:  2015-07-25       Impact factor: 4.256

7.  Proliferation Markers and EGF in ACTH-Secreting Adenomas and Carcinomas of the Pituitary.

Authors:  Dorothee Lubke; Wolfgang Saeger; Dieter K. Ludecke
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

8.  Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.

Authors:  Marianthi Georgitsi; Anniina Raitila; Auli Karhu; Karoliina Tuppurainen; Markus J Mäkinen; Outi Vierimaa; Ralf Paschke; Wolfgang Saeger; Rob B van der Luijt; Timo Sane; Mercedes Robledo; Ernesto De Menis; Robert J Weil; Anna Wasik; Grzegorz Zielinski; Olga Lucewicz; Jan Lubinski; Virpi Launonen; Pia Vahteristo; Lauri A Aaltonen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205

9.  G-protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas.

Authors:  E A Williamson; P G Ince; D Harrison; P Kendall-Taylor; P E Harris
Journal:  Eur J Clin Invest       Date:  1995-02       Impact factor: 4.686

10.  Recurrent gain-of-function USP8 mutations in Cushing's disease.

Authors:  Zeng-Yi Ma; Zhi-Jian Song; Jian-Hua Chen; Yong-Fei Wang; Shi-Qi Li; Liang-Fu Zhou; Ying Mao; Yi-Ming Li; Rong-Gui Hu; Zhao-Yun Zhang; Hong-Ying Ye; Ming Shen; Xue-Fei Shou; Zhi-Qiang Li; Hong Peng; Qing-Zhong Wang; Dai-Zhan Zhou; Xiao-Lan Qin; Jue Ji; Jie Zheng; Hong Chen; Yin Wang; Dao-Ying Geng; Wei-Jun Tang; Chao-Wei Fu; Zhi-Feng Shi; Yi-Chao Zhang; Zhao Ye; Wen-Qiang He; Qi-Lin Zhang; Qi-Sheng Tang; Rong Xie; Jia-Wei Shen; Zu-Jia Wen; Juan Zhou; Tao Wang; Shan Huang; Hui-Jia Qiu; Ni-Dan Qiao; Yi Zhang; Li Pan; Wei-Min Bao; Ying-Chao Liu; Chuan-Xin Huang; Yong-Yong Shi; Yao Zhao
Journal:  Cell Res       Date:  2015-02-13       Impact factor: 25.617

View more
  2 in total

Review 1.  Recent Understanding and Future Directions of Recurrent Corticotroph Tumors.

Authors:  José Miguel Hinojosa-Amaya; César Ernesto Lam-Chung; Daniel Cuevas-Ramos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-26       Impact factor: 5.555

Review 2.  Recent advances in understanding corticotroph pituitary tumor initiation and progression.

Authors:  Ulrich Renner; Denis Ciato; Günter K Stalla
Journal:  F1000Res       Date:  2018-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.